Huijie Yang

urology

H指数:18

被引数:1,050

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Targeting FANCD2 to overcome enzalutamide resistance in prostate cancer

靶向FANCD2以克服前列腺癌中的恩扎卢amide耐药性

Cancer & Metabolism

IF5.3

2026-02-120

OAAI

Correction: RBCK1 regulates the progression of ER-positive breast cancer through the HIF1α signaling

更正：RBCK1通过HIF1α信号通路调节ER阳性乳腺癌的进展。

Cell Death & Disease

IF9.6

2026-02-050

OAAI

Positive feedback regulation between USP8 and Hippo/YAP axis drives triple-negative breast cancer progression

Cell Death & Disease

IF9.6

2026-01-210

OAAI

Synthesis and evaluation of novel 5-HT2A receptor inverse agonist with excellent in vivo antipsychotic efficacy and superior tissue distribution for treatment of Parkinson's disease psychosis

新型5-HT2A受体反向激动剂的合成与评价：具有卓越的体内抗精神病疗效和优越的组织分布，用于治疗帕金森病精神病

European Journal of Medicinal Chemistry

IF5.9

2025-08-050

PRE

Synthesis and Evaluation of a Novel Zuranolone Analog with High GABAA Receptor PAM Activity and Excellent Pharmacokinetic Profiles

新型Zuranolone类似物的合成与评价：具有高GABAA受体PAM活性和优异药代动力学特征

MOLECULES

IF4.6

2025-04-250

USP36 promotes tumorigenesis and tamoxifen resistance in breast cancer by deubiquitinating and stabilizing ERα

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

IF12.8

2024-08-311

OAAI

Tryptanthrin suppresses multiple inflammasome activation to regulate NASH progression by targeting ASC protein

PHYTOMEDICINE

IF8.3

2024-08-011

PRE

YAP represses the TEAD-NF-κB complex and inhibits the growth of clear cell renal cell carcinoma

SCIENCE SIGNALING

IF6.6

2024-07-021

PRE

Novel selective agents for the degradation of AR/AR-V7 to treat advanced prostate cancer

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2024-05-010

PRE

A novel scaffold long-acting selective estrogen receptor antagonist and degrader with superior preclinical profile against ER plus breast cancer

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2024-01-012

PRE

PSMD14 stabilizes estrogen signaling and facilitates breast cancer progression via deubiquitinating ERα

ONCOGENE

IF7.3

2023-11-297

OAAI

Regulation of the Hippo/YAP axis by CXCR7 in the tumorigenesis of gastric cancer

CXCR7调控Hippo/YAP轴在胃癌发生中的作用

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

IF12.8

2023-11-106

OAAI

USP1 modulates hepatocellular carcinoma progression via the Hippo/TAZ axis

CELL DEATH & DISEASE

IF9.6

2023-04-1213

OAAI

RNF31 represses cell progression and immune evasion via YAP/PD-L1 suppression in triple negative breast Cancer

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

IF12.8

2022-12-2913

OAAI

RBCK1 regulates the progression of ER-positive breast cancer through the HIF1α signaling

CELL DEATH & DISEASE

IF9.6

2022-12-067

OAAI

RBCK1 is an endogenous inhibitor for triple negative breast cancer via hippo/YAP axis

CELL COMMUNICATION AND SIGNALING

IF8.9

2022-10-249

OAAI

The ubiquitin ligase RNF2 stabilizes ERα and modulates breast cancer progression

HUMAN CELL

IF3.1

2022-10-214

OAAI

OTUB1 suppresses Hippo signaling via modulating YAP protein in gastric cancer

OTUB1通过调节胃癌中的YAP蛋白抑制Hippo信号

ONCOGENE

IF7.3

2022-10-2135

OAAI

DUB1 suppresses Hippo signaling by modulating TAZ protein expression in gastric cancer

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

IF12.8

2022-07-1212

OAAI

TRIM3 facilitates estrogen signaling and modulates breast cancer cell progression

CELL COMMUNICATION AND SIGNALING

IF8.9

2022-04-0711

OAAI

Huijie Yang

个人简介

教育背景

工作经历

荣誉奖项

研究方向